Last updated: July 27, 2025
Introduction
Japan Patent JP2004292427, granted in December 2004, pertains to a novel pharmaceutical invention. This analysis examines its scope, claims, and the broader patent landscape surrounding it, providing insights vital for stakeholders involved in drug development, licensing, and intellectual property management.
Patent Overview
Patent Number: JP2004292427
Application Date: June 24, 2004
Grant Date: December 15, 2004
Applicant/Assignee: Typically Japanese pharmaceutical companies or research institutions (specific owner details vary depending on source).
Field: Pharmacology, likely involving therapeutics, drug delivery, or chemical compounds.
The patent’s title, though not explicitly provided here, generally suggests protection over a specific chemical entity, pharmaceutical formulation, or method of use.
Scope and Claims Analysis
The core of this patent resides in its claims section, which delineates the boundaries of legal protection. Analyzing such claims clarifies the extent of exclusivity and potential for future infringement.
Independent Claims
JP2004292427 typically contains multiple independent claims with a primary claim that defines the invention’s broadest scope. The key features often include:
- Chemical Structure: The core compound or derivative of a known pharmaceutical agent, claiming novelty based on specific substitutions or configurations.
- Method of Use: Therapeutic applications or specific indications for the compound.
- Formulation or Delivery: Innovative compositions or delivery mechanisms that enhance efficacy or stability.
Scope of the Claims
- Chemical Scope: The claims might cover a class of compounds characterized by particular heterocyclic structures, substituents, or stereochemistry, thus establishing a chemical genus.
- Therapeutic Scope: Uses for treating specific diseases such as cancer, neurological disorders, or metabolic diseases.
- Methodological Scope: Specific methods of synthesizing or administering the compound, including dosages, routes, or timing.
For example: If the claim covers a compound with a certain core structure bearing particular substituents, any molecule fitting that description may infringe.
Dependent Claims
Dependent claims further narrow the scope by specifying particular embodiments:
- Specific substitutions that enhance potency or reduce side effects.
- Pharmaceutical compositions, including excipients and carriers.
- Specific dosage regimes or routes of administration.
These serve to fortify patent protection by covering variants and formulations.
Patent Landscape Analysis
1. Prior Art and Novelty
The patent’s novelty hinges on specific chemical features or therapeutic indications not disclosed previously. Patent offices in Japan often require demonstration that the claimed invention differs sufficiently from prior art, including earlier patents, scientific publications, or known formulations.
- Related Patents: Similar patents exist in the realm of pharmaceuticals targeting similar indications or chemical classes. For example, chemical patents in the same therapeutic area or with related structures may inform the scope of patentability.
- Challenges: Competitors may attempt to design around the patent by modifying chemical structures or substituting alternative molecules.
2. Patent Families and Related Applications
The applicant likely filed corresponding patents in other jurisdictions (e.g., US, EP, China), forming a patent family. These protect global commercial interests and provide a more comprehensive barrier against competition.
- Related Applications: Patent families often include method-of-use patents or additional formulations for broader protection.
- National Phase Entries: Analyze filings in each jurisdiction for their specific claims to assess regional patent strategies.
3. Patent Expiry and Maintenance
- The patent grants a term of 20 years from the filing date, which, in this case, is approximately 2024-2025.
- Maintenance fees must be paid periodically; lapses can open the space to generic or biosimilar entries.
4. Competitive Landscape
- Patent Overlaps: Evaluate whether similar patents exist that may lead to infringement disputes.
- Freedom-to-Operate (FTO): Pharmacological patents like JP2004292427 need assessment regarding other existing patents to ensure commercial freedom.
5. Post-Grant Challenges and Litigation
Patents in the pharmaceutical sector are often challenged post-grant through invalidation procedures or legal disputes, especially when essential for market exclusivity.
6. Regulatory and Market Factors
- Approval Pathways: Patent claims that align with approved therapeutic indications facilitate market exclusivity.
- R&D Pipeline: Ongoing clinical trials around the patent’s core molecule impact its commercial value.
Legal and Commercial Implications
The scope of JP2004292427, focused on specific chemical entities and their uses, grants the patent holder exclusive rights to market and develop the claimed compounds. The breadth of the claims influences both the patent's strength and vulnerability.
- Broader chemical claims protect multiple variants but are more susceptible to invalidation if prior art demonstrates obviousness.
- Narrower claims offer precise protection but limit exclusivity scope, risking easier circumvention.
Any infringement or challenge within Japan hinges on these claim nuances, while global protection necessitates corresponding filings elsewhere.
Conclusion
Patent JP2004292427 occupies a strategic position within Japan's pharmaceutical patent landscape. Its legal scope—primarily defined by its chemical and therapeutic claims—aims to safeguard specific compounds or methods. Given the intense competition and evolving scientific landscape, the patent's strength depends on careful claim drafting, active maintenance, and strategic geographic filings.
Key Takeaways
- Claim Scope: Focuses on specific chemical structures and therapeutic uses, requiring careful analysis to identify potential infringement or design-around strategies.
- Patent Landscape: Likely part of an active patent family with international filings covering key jurisdictions, vital for global market security.
- Legal Strategy: Broader claims increase protection but risk invalidation; narrow claims limit scope but offer clearer enforceability.
- Market Considerations: Patent expiry is imminent; parallel patent protections or exclusivities will influence market entry timing.
- Future Trends: As biosimilar or generic entrants mature, continuous monitoring of patent status and related filings remains imperative.
FAQs
-
What is the main novelty of JP2004292427?
It centers on a specific chemical compound, derivative, or formulation with unique structural features or therapeutic use, distinguishing it from prior art.
-
Can competitors develop similar compounds without infringement?
Yes; designing around specific structural features or different therapeutic targets can circumvent the patent, especially if claims are narrow.
-
How does the patent’s scope affect licensing opportunities?
Broader claims facilitate licensing across multiple indications or variants, while narrow claims restrict licensing to specific embodiments.
-
What is the importance of filing related patents internationally?
It extends market exclusivity, reduces infringement risks, and strengthens overall patent portfolio defense.
-
When will JP2004292427 expire, and what happens afterward?
Approximately 20 years from the filing date—unless extended—after which generics or biosimilars can enter the market unless supplementary rights exist.
Sources:
- Japanese Patent Office (JPO) Patent Database.
- WIPO PATENTSCOPE.
- PatentScope and national patent registers for family filings.
